- Aratana Therapeutics, Inc. stock price today and history
Please, Signup (Login) to subscribe or trade (demo)
Aratana Therapeutics, Inc. stock price
Aratana Therapeutics, Inc. latest news:
BRIEF-Aratana Therapeutics Says Study Did Not Achieve Protocol-Defined Efficacy Success Criteria
Aratana Therapeutics Inc(PETX): * ARATANA THERAPEUTICS ANNOUNCES STUDY RESULTS FOR AT-016. * Aratana Therapeutics Inc(PETX) - ARATANA'S LICENSE PARTNER RESPONSIBLE FOR DEVELOPMENT OF AT-016 SHARED RESULTS OF A PIVOTAL STUDY. * ARATANA THERAPEUTICS (PETX) - RECEIVED TOP-LINE PIVOTAL FIELD EFFECTIVENESS STUDY RESULTS FOR AT-016.
Aratana cancels stock offering after shares plunge
Aratana Therapeutics Inc. canceled plans for a stock offering Tuesday afternoon, one day after it announced the equity issuance and saw its share price plunge in response. The pet-medicine company said in a news release late Tuesday that it was canceling the offering because "current market conditions are not conducive for an offering." After announcing plans to sell at least $35 million in fresh shares Monday evening, Aratana stock plunged 19% in Tuesday's regular trading session to close at $5.86. The stock rebounded after the offering was canceled Tuesday, gaining more than 10% to hit $6.50 in after-hours trading.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Arbutus Biopharma CorporationABUS
ARC Group Worldwide, Inc.ARCW
ARCA biopharma, Inc.ABIO
Arcadia Biosciences, Inc.RKDA
Arch Capital Group Ltd.ACGL
Arctic Cat Inc.ACAT
Arena Pharmaceuticals, Inc.ARNA
Ares Capital CorporationARCC